ADIPOQ and Hyperglycemia: Interestingly, Reiterer et al. showed that SARS-CoV-2 infection induces adipose tissue dysfunction with reduced adiponectin and adiponectin-to-leptin ratio and this may lead to hyperglycaemia and insulin resistance [90], suggesting that inflammation can potentially act as a trigger of metabolic dysfunction.